Recently, two teams of researchers published a paper highlighting the findings of their stem cell clinical trials. The main objective of the entire project was to establish whether a stem cell transplant could reduce or diminish the symptoms of age-related frailty.
As a result of their efforts, it is now more likely that we will see an increased number of tests and hopefully a stamp of approval from the FDA for age frailty treatments in the near future.
According to the researchers who worked on the clinical trials, the main idea behind the study revolved around finding new ways of approaching age frailty through the careful examination of stem cell transplant procedures and their possible benefits.
The findings of two independent clinical trials focusing on the same stem cell transplant research were also published in various medical journals and revealed that the proposed age frailty treatment option was safe and particularly effective.
The papers state that this kind of stem cell treatment designed to specifically target age-related frailty was the most successful of its kind to date.
In the first trial, researchers took 15 frail patients and gave them single dose of MSC infusion consisting of stem cells obtained from the adult bone marrow of various donors aged between 20 to 45 years old. Afterwards, all the trials’ participants displayed signs of improved health, better fitness form, and reduced factor levels of tumor-necrosis.
In the second trial, the tests were random and included a placebo group. However, aside from noting no significant effects, researchers state the improvements seen were remarkable.
Both of the studies mentioned above concentrated on primarily establishing how safe the MSCs (Mesenchymal Stem Cells) transplant option is, and the results obtained showcase just how effective the treatment could be.
This situation has come as a welcomed relief after so much work done in this field, over the last few years we have seen an abundant number of scientific papers and studies being published in an effort to try and figure out new ways of treating aging.
In fact, these types of studies and clinical trials have become even more critical since doctors are now more than ever accepting the idea that aging could be a disease that indeed requires treatment. However, more needs to be done for this concept to become the standard in medical practice worldwide.
One clear sign that the fight for better anti-aging treatments is taking a turn for the better is the increased funding for research. In fact, increased funds can be seen coming from private companies that are looking to find the proverbial and evasive fountain of youth which would change how we age and how life-threatening diseases are treated.